NEW YORK (GenomeWeb) – Spanish healthcare products firm Grifols said today that it has invested $50 million for a 20 percent stake in diagnostics and laboratory testing services firm Singulex. 

According to a filing with the US Securities and Exchange Commission, the investment has a fully diluted pre-money valuation of $200 million and entitles Grifols to appoint a director to Singulex's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.